COVID - 19 Vaccination Update - Day 512 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 11 JUN 2022 8:04PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 195 Crore (1,95,05,33,258) landmark milestone today. More than 11 lakh (11,30,430) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10407622
	2^nd Dose	10047748
	Precaution Dose	5393811
FLWs	1^st Dose	18420512
	2^nd Dose	17597227
	Precaution Dose	9173913
Age Group 12-14 years	1^st Dose	35115616
	2^nd Dose	19364579
Age Group 15-18 years	1^st Dose	59845102
	2^nd Dose	46940188
Age Group 18-44 years	1^st Dose	557570453
	2^nd Dose	494470106
	Precaution Dose	1494920
Age Group 45-59 years	1^st Dose	203320154
	2^nd Dose	191829604
	Precaution Dose	1802126
Over 60 years	1^st Dose	127149725
	2^nd Dose	119709482
	Precaution Dose	20880370
Cumulative 1^st dose administered		1011829184
Cumulative 2^nd dose administered		899958934
Precaution Dose		38745140
Total		1950533258

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 11^th June, 2022 (512^th Day)
HCWs	1^st Dose	44
	2^nd Dose	477
	Precaution Dose	12808
FLWs	1^st Dose	63
	2^nd Dose	1078
	Precaution Dose	31107
Age Group 12-14 years	1^st Dose	73395
	2^nd Dose	191067
Age Group 15-18 years	1^st Dose	26597
	2^nd Dose	83383
Age Group 18-44 years	1^st Dose	29560
	2^nd Dose	306257
	Precaution Dose	89773
Age Group 45-59 years	1^st Dose	5104
	2^nd Dose	67799
	Precaution Dose	47196
Over 60 years	1^st Dose	4913
	2^nd Dose	47838
	Precaution Dose	111971
Cumulative 1^st dose administered		139676
Cumulative 2^nd dose administered		697899
Precaution Dose		292855
Total		1130430

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.